External Scientific Advisory Board

Programmes and the financial framework are reviewed and approved by the External Scientific Advisory board. This body meets on site every two years to oversee the general development of the IZKF and the proposed projects. Between the on-site reviews research proposals are sent out for review. The next meeting of the SAB is scheduled for November 2015. The Board consists of at least 10 internationally recognised scientists (currently 15) from universities and research institutes led by an elected chairperson. Members are appointed by the University president, upon the proposal of the Management Board, for a period of six years.


Members of the External Scientific Advisory Board


Prof. Dr. Thomas Seufferlein ↗
University Hospital Ulm – Internal Medicine I

Vice Chair

Prof. Dr. Tanja Kuhlmann ↗
University Hospital Münster, Institute of Neuropathology


Prof. Dr. Dirk Busch ↗
Technical University of Munich, Institute for Medical Microbiology, Immunology and Hygiene
Prof. Dr. Ulf Dittmer
Essen University Hospital, Institute of Virology
Prof. Dr. Ulrich Kalinke ↗
TWINCORE, Centre for Experimental and Clinical Infection Research
Prof. Dr. Thomas Kamradt ↗
Jena University Hospital, Institute of Immunology
Prof. Dr. Dörthe Katschinski ↗
Göttingen University Medical Center – Department of Cardiovascular Physiology
Prof. Dr. Holger Moch ↗
University Hospital Zurich, Institute of Pathology and Molecular Pathology
Prof. Dr. Peter R. Mertens
University Hospital Magdeburg, University Clinic for Nephrology and Hypertension, Diabetology and Endocrinology

Prof. Dr. Jörg Prinz ↗
LMU München, Department of Dermatology and Allergology
Prof. Dr. Jörg B. Schulz ↗
University Hospital Aachen – Department of Neurology
Prof. Dr. Reiner Siebert ↗
University Hospital Ulm, Institute of Human Genetics
Prof. Dr. Lydia Sorokin ↗
University of Münster, Institute of Physiological Chemistry and Pathobiochemistry
Prof. Dr. Gisa Tiegs ↗
Hamburg-Eppendorf University Medical Center – Insitute of Experimental Immunology and Hepatology
Prof. Dr. Konstanze F. Winklhofer
Ruhr-University Bochum, Chair, Dept. of Molecular Cell Biology, Institute of Biochemistry and Pathobiochemistry